2026. INVESTIGATING THE CLINICAL OUTCOMES OF COMBINATION IMMUNOTHERAPY AND TARGETED THERAPY IN ADVANCED NON SMALL CELL LUNG CANCER PATIENTS. Biosciences Reports. 3, 01 (Jun. 2026), 24–46.